High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study

Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use

(2014) G.L. Daikos et al.   JOURNAL OF CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration

(2010) Roberto Imberti et al.   CHEST

Pharmacokinetic evaluation of colistin sodium

(2010) Argyris S Michalopoulos et al.   Expert Opinion on Drug Metabolism & Toxicology

Predictors of acute kidney injury associated with intravenous colistin treatment

(2010) Jeong-Ah Kwon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections

(2010) Chien-Yu Cheng et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors for colistin-associated nephrotoxicity

(2010) Pinyo Rattanaumpawan et al.   JOURNAL OF INFECTION

Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin

(2010) Hee ja Ko et al.   NEPHRON CLINICAL PRACTICE

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

(2009) Joshua D. Hartzell et al.   CLINICAL INFECTIOUS DISEASES

Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*

(2009) Andrew F. Shorr   CRITICAL CARE MEDICINE

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

(2008) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study

(2008) Nikolaos Markou et al.   CLINICAL THERAPEUTICS

A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients

(2008) S. M. Bagshaw et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION